ESR1 and triple-negative breast carcinoma: Furthermore, low expression of GR has been associated with poorer outcome in estrogen receptor (ER) positive breast cancers [72], and the GR gene NR3C1 has been reported to be mutated in triple-negative breast cancers, indicating that inactivation of GR is part of the transformation process in these tumours [73].